5WG-11553-39623
4 vaccinations
5 coded responses
49 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 681 / NE
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Moderna
- 2021-01-12
- 2021-01-13
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling, Itching · HeadacheAdult check-in
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-26
- 2021-02-02
- 2021-02-09
-
2021-02-11
Dose 2 — Moderna
-
2021-02-16
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain — Feeling: Good · Site: Pain, Swelling, ItchingFree text: Lymph node tenderness in clavicle area, same side as vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
- 2021-02-18
- 2021-02-25
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-05-13
- 2021-08-12
-
2021-10-27
Dose 3 — Moderna
-
2021-10-27
Health check-in — day 0, dose 3Feeling: Good · Site: Swelling · Fatigue or tirednessAdult check-in
-
2021-10-28
Survey response — days 1–6 daily, dose 3MedDRA: Lymph node pain — Feeling: Good · Site: Pain, SwellingFree text: Tender above clavicle & anterior axilla area (injection side lymph nodes)MedDRA releases: 2024-11 · check-in free text available
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Supraclavicular fossa pain — Feeling: Good · Site: SwellingFree text: Pain persists in supraclavicular fossa (inj. side)MedDRA releases: 2024-11 · check-in free text available
-
2021-10-30
Survey response — days 1–6 daily, dose 3MedDRA: Tenderness — Feeling: Good · Site: PainFree text: Tender supraclavicular fossa, inj. sideMedDRA releases: 2024-11 · check-in free text available
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-11
- 2021-11-17
- 2021-11-24
- 2021-12-01
- 2021-12-08
- 2022-01-26
-
2022-04-10
Dose 4 — Moderna
- 2022-04-10
- 2022-04-11
- 2022-04-12
- 2022-04-13
- 2022-04-14
- 2022-04-15
- 2022-04-16
- 2022-04-17
- 2022-04-24
- 2022-05-01
- 2022-05-08
- 2022-05-15
- 2022-05-22
-
2022-07-10
Survey response — 3 months, dose 4MedDRA: Back pain, Cough, Exposure to SARS-CoV-2, Fatigue, Headache, Migraine, Pain, Pharyngitis, Respiratory tract congestion, Rhinitis, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Covid-19 exposure 7/1/22. Symptoms 7/2: backache, 7/3: Cough, 7/4: severe headache (migraine features), 7/5-7-9: congestion, painful pharyngitis, sneezing, fatigue, lumbar pain, rhinitis. Treated with Molnupiravir.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-10
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-11
- 2022-10-09
- 2023-04-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Moderna | |
| 2 | 2021-02-11 | Moderna | |
| 3 | 2021-10-27 | Moderna | No |
| 4 | 2022-04-10 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Lymph node tenderness in clavicle area, same side as vaccine
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Tender above clavicle & anterior axilla area (injection side lymph nodes)
Systemic reaction (other): Pain persists in supraclavicular fossa (inj. side)
Systemic reaction (other): Tender supraclavicular fossa, inj. side
Release 12 — 3 months, dose 4
Symptoms: Covid-19 exposure 7/1/22. Symptoms 7/2: backache, 7/3: Cough, 7/4: severe headache (migraine features), 7/5-7-9: congestion, painful pharyngitis, sneezing, fatigue, lumbar pain, rhinitis. Treated with Molnupiravir.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pharyngitis | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinitis | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Supraclavicular fossa pain | · | · | ✓ |
| SRO | Tenderness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release